{"id":"high-severity-group-escitalopram","safety":{"commonSideEffects":[{"rate":"15-20","effect":"Nausea"},{"rate":"10-15","effect":"Headache"},{"rate":"10-15","effect":"Insomnia"},{"rate":"5-10","effect":"Somnolence"},{"rate":"10-15","effect":"Sexual dysfunction"},{"rate":"5-10","effect":"Diarrhea"},{"rate":"5-10","effect":"Dry mouth"},{"rate":"5-10","effect":"Sweating"}]},"_chembl":{"chemblId":"CHEMBL1200322","moleculeType":"Small molecule","molecularWeight":"414.43"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Escitalopram is the active S-enantiomer of citalopram and works as a selective serotonin reuptake inhibitor (SSRI). By blocking the serotonin transporter protein, it prevents the reabsorption of serotonin from the synaptic cleft back into presynaptic neurons, thereby increasing serotonin concentration and enhancing neurotransmission. This mechanism is thought to improve mood and reduce anxiety symptoms in psychiatric disorders.","oneSentence":"Escitalopram selectively inhibits the reuptake of serotonin at the neuronal synapse, increasing serotonin availability in the brain.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:22:26.955Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Major depressive disorder"},{"name":"Generalized anxiety disorder"},{"name":"Panic disorder"},{"name":"Social anxiety disorder"},{"name":"Obsessive-compulsive disorder"}]},"trialDetails":[{"nctId":"NCT05528224","phase":"NA","title":"Effect of SC-ICBT for Adults With OCD：A Three-Arm Randomized Controlled Trial","status":"TERMINATED","sponsor":"Shanghai Mental Health Center","startDate":"2022-09-01","conditions":"Obsessive-Compulsive Disorder","enrollment":46},{"nctId":"NCT01324700","phase":"PHASE4","title":"Antidepressant Treatment at an Inner City Asthma Clinic","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2010-07","conditions":"Depression, Asthma","enrollment":139}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":47,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Lexapro, Selective serotonin reuptake inhibitor (SSRI)"],"phase":"marketed","status":"active","brandName":"High severity group: Escitalopram","genericName":"High severity group: Escitalopram","companyName":"University of Texas Southwestern Medical Center","companyId":"university-of-texas-southwestern-medical-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Escitalopram selectively inhibits the reuptake of serotonin at the neuronal synapse, increasing serotonin availability in the brain. Used for Major depressive disorder, Generalized anxiety disorder, Panic disorder.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}